Literature DB >> 30796952

A novel Kunitz protein with proposed dual function from Eudiplozoon nipponicum (Monogenea) impairs haemostasis and action of complement in vitro.

Lucie Jedličková1, Jan Dvořák2, Ingrid Hrachovinová3, Lenka Ulrychová4, Martin Kašný5, Libor Mikeš6.   

Abstract

Serine peptidases are involved in many physiological processes including digestion, haemostasis and complement cascade. Parasites regulate activities of host serine peptidases to their own benefit, employing various inhibitors, many of which belong to the Kunitz-type protein family. In this study, we confirmed the presence of potential anticoagulants in protein extracts of the haematophagous monogenean Eudiplozoon nipponicum which parasitizes the common carp. We then focused on a Kunitz protein (EnKT1) discovered in the E. nipponicum transcriptome, which structurally resembles textilinin-1, an antihemorrhagic snake venom factor from Pseudonaja textilis. The protein was recombinantly expressed, purified and biochemically characterised. The recombinant EnKT1 did inhibit in vitro activity of Factor Xa of the coagulation cascade, but exhibited a higher activity against plasmin and plasma kallikrein, which participate in fibrinolysis, production of kinins, and complement activation. Anti-coagulation properties of EnKT1 based on the inhibition of Factor Xa were confirmed by thromboelastography, but no effect on fibrinolysis was observed. Moreover, we discovered that EnKT1 significantly impairs the function of fish complement, possibly by inhibiting plasmin or Factor Xa which can act as a C3 and C5 convertase. We localised Enkt1 transcripts and protein within haematin digestive cells of the parasite by RNA in situ hybridisation and immunohistochemistry, respectively. Based on these results, we suggest that the secretory Kunitz protein of E. nipponicum has a dual function. In particular, it impairs both haemostasis and complement activation in vitro, and thus might facilitate digestion of a host's blood and protect a parasite's gastrodermis from damage by the complement. This study presents, to our knowledge, the first characterisation of a Kunitz protein from monogeneans and the first example of a parasite Kunitz inhibitor that impairs the function of the complement.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Anticoagulant; Diplozoidae; Factor X; Haematophagy; Helminth; Kunitz; Peptidase inhibitor; Plasmin

Mesh:

Substances:

Year:  2019        PMID: 30796952     DOI: 10.1016/j.ijpara.2018.11.010

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  4 in total

1.  Laser capture microdissection in combination with mass spectrometry: Approach to characterization of tissue-specific proteomes of Eudiplozoon nipponicum (Monogenea, Polyopisthocotylea).

Authors:  Pavel Roudnický; David Potěšil; Zbyněk Zdráhal; Milan Gelnar; Martin Kašný
Journal:  PLoS One       Date:  2020-06-17       Impact factor: 3.240

2.  Eudiplozoon nipponicum (Monogenea, Diplozoidae) and its adaptation to haematophagy as revealed by transcriptome and secretome profiling.

Authors:  Jiří Vorel; Krystyna Cwiklinski; Pavel Roudnický; Jana Ilgová; Lucie Jedličková; John P Dalton; Libor Mikeš; Milan Gelnar; Martin Kašný
Journal:  BMC Genomics       Date:  2021-04-15       Impact factor: 3.969

3.  Bioinformatic comparison of Kunitz protease inhibitors in Echinococcus granulosus sensu stricto and E. multilocularis and the genes expressed in different developmental stages of E. granulosus s.s.

Authors:  Hui Zhang; Mengxiao Tian; Wenjing Qi; Juan Wu; Huajun Zheng; Gang Guo; Liang Zhang; Shiwanthi L Ranasinghe; Donald P McManus; Jun Li; Wenbao Zhang
Journal:  BMC Genomics       Date:  2021-12-18       Impact factor: 3.969

Review 4.  Review on the molecular study of the Diplozoidae: analyses of currently available genetic data, what it tells us, and where to go from here.

Authors:  Quinton Marco Dos Santos; Annemariè Avenant-Oldewage
Journal:  Parasit Vectors       Date:  2020-10-30       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.